SciFi Futures
← Capabilities
Biotech & Medicine/Materials

Low-toxicity vitrification agents

Cryoprotectant cocktails that stop ice formation throughout a large perfused tissue at concentrations the cells survive.

State of the art

VS55 and M22 vitrification cocktails combined with iron-oxide nanoparticles enabled recovery of vitrified rat kidneys (2023); a non-metabolizable sugar plus ice-nucleating Snomax allowed partial-freezing storage of human livers for days (2023).

What’s blocking it
  • Cryoprotectant concentrations that prevent ice (over 50 percent w/v) are chemically toxic over the hours needed to load a large organ
  • Perfusion is uneven - poorly vascularized regions receive too little agent and nucleate ice
  • Devitrification during rewarming happens faster than agents can suppress in large volumes

Who’s working on it

  • John BischofResearcher
    University of Minnesota

    Directs NSF ATP-Bio; his group's iron-oxide nanowarming plus M22-class cocktails enabled recovery of vitrified rat kidneys (2023) and, with MGH, the first transplant of a cryopreserved large-mammal kidney

  • NSF Engineering Research Center (grant EEC-1941543) co-led by the University of Minnesota and Mass General Brigham; its Year 4 report cites $30M of leveraged non-ERC funding and it was the only ERC highlighted in NSF's FY2027 budget request

  • Building reversible organ cryopreservation end to end; reported expanding its cryoprotectant discovery engine from dozens to over 250,000 candidate molecules (2026) alongside organ-scale magnetic rewarming

  • Shannon TessierResearcher
    Massachusetts General Hospital

    Developed partial-freezing and supercooling protocols, including non-metabolisable sugar plus ice-nucleation storage that kept human livers viable for days (2023)

  • 21st Century MedicineCompany

    Developed the VS55 and M22 vitrification cocktails that remain the field's reference formulations, and the first vitrified-and-rewarmed rabbit kidney work

  • NSF EARTH Engineering Research CenterProgram

    NSF center (grant ECC-2330175) at the University of Kansas working with ATP-Bio on liquid refrigerants that cool organs fast enough to cut required cryoprotectant concentrations

What to invest in

KindInvestmentScale
researchHigh-throughput screening of ice-binding proteins and sugar mixtures ranked by glass-forming ability per unit toxicity$$ $10M – $100M
engineeringInstrumented perfusion rigs that map agent concentration spatially in organ-scale tissue during loading$$ $10M – $100M

Sci-fi concepts in reach

Cryosleep for interstellar flightdirectRevival of the cryopreserved deadindirect

Sources